Results 91 to 100 of about 4,155 (158)

Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort. [PDF]

open access: yesRMD Open, 2022
Ciurea A   +15 more
europepmc   +1 more source

Upadacitinib in active non-radiographic axial spondyloarthritis: 2-year data from the phase 3 SELECT-AXIS 2 study. [PDF]

open access: yesArthritis Res Ther
Van den Bosch F   +13 more
europepmc   +1 more source

Secukinumab in non-radiographic axial spondyloarthritis: subgroup analysis based on key baseline characteristics from a randomized phase III study, PREVENT. [PDF]

open access: yesArthritis Res Ther, 2021
Braun J   +14 more
europepmc   +1 more source

Effectiveness of secukinumab in radiographic and non-radiographic axial spondyloarthritis: a European routine-care observational study. [PDF]

open access: yesRMD Open
Christiansen SN   +38 more
europepmc   +1 more source

Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial. [PDF]

open access: yesRheumatol Ther, 2021
Deodhar A   +12 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy